2024 annual financial data
Actuate Therapeutics 2024 Operating margin
Actuate Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -25,160,734 USD and net income was -27,285,328 USD.
Operating cash flow was -21,842,648 USD.
Get free Actuate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -25,160,734 USD
- Net income
- -27,285,328 USD
- Operating cash flow
- -21,842,648 USD